What are the signs and symptoms of colon and rectal cancer? Dana-Farber's Jeffrey Meyerhardt, MD talks about symptoms, screening, and what you can do to prevent colon and rectal cancer. Learn more about the Colon and Rectal Cancer Center at Dana-Farber Cancer Institute: http://www.dana-farber.org/col....on-and-rectal-cancer

In 2015 Ron was diagnosed with stage 4 colorectal cancer. He received traditional, but debilitating, chemotherapy treatment for 9 months. #CIM18 #PatientStories

He wasn’t able to eat or sleep, and his devastated wife, Maria, searched for other options. In 2016, after learning he carried a genetic mutation linked to Lynch syndrome, Ron began a nivolumab/ipilimumab combination immunotherapy on a clinical trial at the University of Pittsburgh Medical Center. Today, Ron continues to receive nivo/ipi as part of routine care and, for the past 2 years, has had no evidence of disease progression. “I am able to live on immunotherapy,” Ron explained. http://www.cancerresearch.org/patients

This video is presented as part of the Cancer Research Institute 6th Annual Cancer Immunotherapy Month awareness campaign this June 2018. Learn more about cancer immunotherapy and its potential to save more lives at http://www.cancerresearch.org/june.

Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

**
Ron passed away in December 2018. His family feels grateful for the additional time and quality of life that immunotherapy provided Ron, and hope that someday immunotherapy is considered first-line therapy for more types of cancer.”

Dr. Steven Nurkin shares various options for colorectal cancer treatment, and explains what sets Roswell Park apart when it comes to treating colon cancer. Learn more: https://www.roswellpark.org/ca....ncer/colorectal/trea

Leading colorectal surgeon Mr Jonathan Wilson discusses which surgical procedures are available to patients to treat their colon cancer, and what happens.

Book an appointment to see Mr Wilson: https://www.topdoctors.co.uk/d....octor/jonathan-wilso

Jenny Seligmann, MBChB, PhD, University of Leeds, Leeds, UK, provides an overview of the Phase III FOxTROT trial (NCT00647530), which assessed neoadjuvant chemotherapy in patients with locally advanced colorectal cancer. Patients received either neoadjuvant FOLFOX followed by surgery and more chemotherapy, or the standard of care with only surgery and post-operative chemotherapy. Disease-free survival (DFS), the primary endpoint, was met, and patients with T4 tumors benefited the most, whereas microsatellite instability high (MSI-H) patients tended to have poorer outcomes. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

View our new feature exploring genomic biomarkers in metastatic colorectal cancer here: https://bit.ly/3DcSevZ

Tonia Young-Fadok, M.D., a colorectal surgeon at Mayo Clinic in Arizona, discusses what to expect during the recovery process following surgery for colorectal cancer. To learn more about colorectal cancer care at Mayo Clinic, visit: https://mayocl.in/2sDvtQv